The interactions with tirzepatide combinations require medical oversight to manage safely
What sets tirzepatide apart from other similar medications is its ability to target two receptors in the body: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
Same tirzepatide molecule as Zepbound same doses, different branding and insurance coverage category
Adults were required to have at least one self-reported unsuccessful dietary effort to lose weight to participate in the trial
PubMed Kosiborod, M.N., Abildstrm, S.Z., Borlaug, B.A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G.K., Kitzman, D.W., Lindegaard, M.L., Mller, D.V., Shah, S.J., Treppendahl, M.B., Verma, S., Petrie, M.C., & SUMMIT Investigators